Late Stage Investors & VC Firms in Germany
98 firms in this list, with a median first check of $1M. 8 of them lead rounds. Generated from verified public data and updated continuously.
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
11 people
BayBG Bayerische Beteiligungsgesellschaft mbH
MunichSeed–Late Stage$270K – $10.8M
11 people
EQT Life Sciences
AmsterdamSeries A–Late Stage$10.8M – $64.8M
11 people
European Circular Bioeconomy Fund
BonnGrowth–Late Stage$2.7M – $10.8M
11 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $32.4M
11 people
Gimv
MunichGrowth–Late Stage$5.4M – $162M
11 people
SHS Capital
TuebingenGrowth–Late Stage$2.2M – $21.6M
11 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
REV Venture Partners
San FranciscoSeed–Late Stage$1M – $10M
3 people
Eurazeo
ParisSeries A–Late Stage
11 people
Isomer Capital
LondonSeed–Late Stage
11 people
TVM Capital
MunchenSeed–Late Stage$1.1M – $16.2M
8 people
Yttrium
Frankfurt am MainGrowth–Late Stage
11 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
7 people
2150
LondonSeed–Late Stage
10 people
Future Energy Ventures
BerlinSeed–Late Stage$1.1M – $5.4M
7 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
7 people
LBBW Venture Capital GmbH
StuttgartSeed–Late Stage$540K – $5.4M
7 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Forbion
AmsterdamPre-Seed–Late Stage
1 person
3VC
ViennaSeries A–Late Stage$1.1M
6 people
Ajax Health
Menlo ParkSeed–Late Stage
9 people
Armira
MunichGrowth–Late Stage$10M – $200M
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
6 people
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)Growth Investors & VC Firms (1963)Series C Investors & VC Firms (1701)
Data sourced from public filings and firms' own websites — see our methodology.